Compare PAGS & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAGS | PBH |
|---|---|---|
| Founded | 2006 | 1996 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.0B |
| IPO Year | N/A | 2005 |
| Metric | PAGS | PBH |
|---|---|---|
| Price | $9.61 | $61.52 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | $11.71 | ★ $86.40 |
| AVG Volume (30 Days) | ★ 3.7M | 438.5K |
| Earning Date | 02-19-2026 | 02-05-2026 |
| Dividend Yield | ★ 1.44% | N/A |
| EPS Growth | ★ 16.68 | N/A |
| EPS | 1.37 | ★ 4.04 |
| Revenue | ★ $3,662,823,389.00 | $1,110,479,000.00 |
| Revenue This Year | $14.61 | N/A |
| Revenue Next Year | $5.39 | $2.50 |
| P/E Ratio | ★ $7.12 | $15.40 |
| Revenue Growth | ★ 10.88 | N/A |
| 52 Week Low | $6.11 | $57.25 |
| 52 Week High | $11.16 | $90.04 |
| Indicator | PAGS | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 46.36 | 49.85 |
| Support Level | $9.61 | $61.72 |
| Resistance Level | $9.86 | $63.91 |
| Average True Range (ATR) | 0.24 | 1.25 |
| MACD | -0.03 | 0.05 |
| Stochastic Oscillator | 26.79 | 30.22 |
PagSeguro Digital Ltd is a Brazilian-based company that acts as a provider of financial technology solutions focused on Micro-Merchants, Small Companies and Medium-Sized Companies (SMEs), in Brazil. The company provides a range of solutions and tools such as cash-in and cash-out options and provides access to working capital to help to manage its cash flow. It delivers an end-to-end digital ecosystem to address day-to-day financial needs, including receiving and spending funds and managing and growing businesses for clients. The company also offers the Free PagSeguro Digital Account delivering Cash-In Solutions, Online and In-Person Payment Tools, Online Payment Tools; and Web Check Outs offer tokenization, handling of shipping information, and others.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.